Next Article in Journal
Looking at Thyroid Cancer from the Tumor-Suppressor Genes Point of View
Next Article in Special Issue
Metastatic Clear-Cell Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors: Therapies and Ongoing Trials
Previous Article in Journal
Adverse Events in 1406 Patients Receiving 13,780 Cycles of Azacitidine within the Austrian Registry of Hypomethylating Agents—A Prospective Cohort Study of the AGMT Study-Group
Previous Article in Special Issue
Immune Checkpoint Inhibitors for Genitourinary Cancers: Treatment Indications, Investigational Approaches and Biomarkers
 
 
Review

Article Versions Notes

Cancers 2022, 14(10), 2460; https://doi.org/10.3390/cancers14102460
Action Date Notes Link
article xml file uploaded 17 May 2022 08:47 CEST Original file -
article xml uploaded. 17 May 2022 08:47 CEST Update https://www.mdpi.com/2072-6694/14/10/2460/xml
article pdf uploaded. 17 May 2022 08:47 CEST Version of Record https://www.mdpi.com/2072-6694/14/10/2460/pdf
article html file updated 17 May 2022 08:49 CEST Original file -
article html file updated 3 August 2022 00:12 CEST Update https://www.mdpi.com/2072-6694/14/10/2460/html
Back to TopTop